Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Cooper-Standard Holdings Inc is an auto parts business based in the US. Cooper-Standard shares (CPS) are listed on the NYSE and all prices are listed in US Dollars. Cooper-Standard employs 25,000 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $22.44 |
|---|---|
| 52-week range | $17.05 - $47.85 |
| 50-day moving average | $23.40 |
| 200-day moving average | $26.05 |
| Wall St. target price | $33.50 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-14.58 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $22.44 from 2022-01-20
| 1 week (2022-01-14) | -17.83% |
|---|---|
| 1 month (2021-12-22) | 13.79% |
| 3 months (2021-10-22) | -9.92% |
| 6 months (2021-07-22) | -7.54% |
| 1 year (2021-01-22) | -35.61% |
|---|---|
| 2 years (2020-01-21) | -27.61% |
| 3 years (2019-01-18) | 74.21 |
| 5 years (2017-01-20) | 103.9 |
Valuing Cooper-Standard stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cooper-Standard's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cooper-Standard's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.22. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Cooper-Standard's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Cooper-Standard's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $43.1 million.
The EBITDA is a measure of a Cooper-Standard's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2.4 billion |
|---|---|
| Gross profit TTM | $147.5 million |
| Return on assets TTM | -2.51% |
| Return on equity TTM | -48.52% |
| Profit margin | -10.22% |
| Book value | $23.14 |
| Market capitalisation | $464 million |
TTM: trailing 12 months
We're not expecting Cooper-Standard to pay a dividend over the next 12 months.
Cooper-Standard's shares were split on a 4:1 basis on 12 November 2007. So if you had owned 1 share the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your Cooper-Standard shares – just the quantity. However, indirectly, the new 75% lower share price could have impacted the market appetite for Cooper-Standard shares which in turn could have impacted Cooper-Standard's share price.
Over the last 12 months, Cooper-Standard's shares have ranged in value from as little as $17.05 up to $47.85. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Cooper-Standard's is 3.1409. This would suggest that Cooper-Standard's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Cooper-Standard Holdings Inc. , through its subsidiary, Cooper-Standard Automotive Inc. , designs, manufactures, and sells sealing, fuel and brake delivery, and fluid transfer systems worldwide. The company's sealing systems include obstacle detection sensor system, flush glass systems, dynamic seals, variable extrusion systems, static seals, specialty sealing products, encapsulated glasses, stainless steel trims, and textured surfaces with cloth appearance. Its fuel and brake delivery systems comprise chassis and tank fuel lines and bundles, direct injection and port fuel rails, metallic brake lines and bundles, tube coatings, quick connects, and brake jounce lines. The company's fluid transfer systems consist of heater/coolant hoses, turbo charger hoses, quick connects, charged air cooler ducts/assemblies, DPF and SCR emission lines, secondary air hoses, degas tanks, brake and clutch hoses, air intake and charge systems, and transmission oil cooling hoses. The company's products are primarily used in passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers and replacement markets.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.